REGENXBIO, Inc. (RGNX)
7.43
+0.01
(+0.13%)
USD |
NASDAQ |
Oct 02, 16:00
7.54
+0.11
(+1.48%)
After-Hours: 20:00
REGENXBIO Market Cap : 402.44M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 402.44M |
| October 01, 2026 | 401.90M |
| September 30, 2026 | 407.85M |
| September 29, 2026 | 403.52M |
| September 28, 2026 | 404.61M |
| September 25, 2026 | 400.81M |
| September 24, 2026 | 392.15M |
| September 23, 2026 | 406.23M |
| September 22, 2026 | 441.44M |
| September 21, 2026 | 426.81M |
| September 18, 2026 | 434.94M |
| September 17, 2026 | 444.96M |
| September 16, 2026 | 432.23M |
| September 15, 2026 | 430.33M |
| September 14, 2026 | 470.69M |
| September 11, 2026 | 462.02M |
| September 10, 2026 | 463.64M |
| September 09, 2026 | 472.85M |
| September 08, 2026 | 474.48M |
| September 04, 2026 | 484.23M |
| September 03, 2026 | 498.31M |
| September 02, 2026 | 519.97M |
| September 01, 2026 | 504.81M |
| August 31, 2026 | 514.56M |
| August 28, 2026 | 523.22M |
| Date | Value |
|---|---|
| August 27, 2026 | 507.52M |
| August 26, 2026 | 508.06M |
| August 25, 2026 | 482.60M |
| August 24, 2026 | 436.29M |
| August 21, 2026 | 580.64M |
| August 20, 2026 | 599.05M |
| August 19, 2026 | 651.05M |
| August 18, 2026 | 599.60M |
| August 17, 2026 | 613.68M |
| August 14, 2026 | 583.08M |
| August 13, 2026 | 577.39M |
| August 12, 2026 | 590.93M |
| August 11, 2026 | 576.85M |
| August 10, 2026 | 564.39M |
| August 07, 2026 | 580.64M |
| August 06, 2026 | 610.97M |
| August 05, 2026 | 568.72M |
| August 04, 2026 | 557.89M |
| August 03, 2026 | 514.11M |
| July 31, 2026 | 500.17M |
| July 30, 2026 | 522.36M |
| July 29, 2026 | 496.56M |
| July 28, 2026 | 495.52M |
| July 27, 2026 | 501.20M |
| July 24, 2026 | 502.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 464.42B |
| United Therapeutics Corp. | 23.12B |
| Ardelyx, Inc. | 832.15M |
| Biomea Fusion, Inc. | 92.05M |
| RenovoRx, Inc. | 71.29M |
Market Cap Related Metrics
| PS Ratio | 2.224 |
| PEG Ratio | -0.2121 |
| Price to Book Value | 5.608 |
| Price | 7.43 |
| Earnings Yield | -50.94% |
| PEGY Ratio | -0.2121 |